Obertshausen, Germany

Julia Quathamer

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Julia Quathamer: Innovator in Biofunctional Composition Sterilization

Introduction

Julia Quathamer is a notable inventor based in Obertshausen, Germany. She has made significant contributions to the field of biofunctional compositions, particularly in sterilization methods. With a total of two patents to her name, her work is recognized for its innovative approach to enhancing the safety and efficacy of biomolecules.

Latest Patents

Julia's latest patents focus on the means and methods of sterilization of biofunctional compositions. The inventions relate to a closed sterilized container that includes at least one carrier acting as a stabilizer. This carrier is designed to reversibly attach to at least one biomolecule, which is partially or completely covered by the carrier. The carrier can be selected from a variety of substances, including (poly)peptides, amino acids, polyalcohols, and ionic liquids, among others. The patents also detail methods for producing these sterilized containers and their various uses.

Career Highlights

Julia Quathamer is currently associated with Leukocare AG, a company that specializes in the development of innovative solutions for the stabilization and storage of biomolecules. Her work at Leukocare AG has positioned her as a key player in the field of biopharmaceuticals.

Collaborations

Julia has collaborated with notable colleagues such as Jens Altrichter and Anja Breuer. These partnerships have contributed to her success and the advancement of her research in biofunctional compositions.

Conclusion

Julia Quathamer's innovative work in the sterilization of biofunctional compositions showcases her expertise and commitment to advancing the field. Her contributions are vital for the development of safer and more effective biopharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…